This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Criscuoli, G.
Right arrow Articles by Pisacane, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Criscuoli, G.
Right arrow Articles by Pisacane, A.
Related Collections
Right arrow Dentistry & Otolaryngology

PEDIATRICS Vol. 111 No. 3 March 2003, pp. e236-e238

ELECTRONIC ARTICLE

Frequency of Surgery Among Children Who Have Adenotonsillar Hypertrophy and Improve After Treatment With Nasal Beclomethasone

Gaetano Criscuoli, MD*, Stefania D’Amora, MD*, Giuseppe Ripa, MD{ddagger}, Giovanni Cinquegrana, MD{ddagger}, Nicola Mansi, MD{ddagger}, Nicola Impagliazzo, MD{ddagger} and Alfredo Pisacane, MD, MSc*

* Dipartimento di Pediatria, Università di Napoli Federico II, Napoli, Italy
{ddagger} Unità Operativa di Otorinolaringoiatria Pediatrica, Azienda Ospedaliera Santobono-Pausilipon, Napoli, Italy

--> Objective. To describe the long-term outcome of a cohort of children with symptomatic adenotonsillar hypertrophy treated with aqueous nasal beclomethasone.

Methods. The children enrolled completed a 4-week single-blind, saline solution controlled crossover study of aqueous beclomethasone (total: 400 µg/d). In a 24-week open-label follow-on study, beclomethasone 200 µg/d was offered to all patients. During a 100-week follow-up, the degree of nasal obstruction and the frequency of adenotonsillectomy were assessed.

Results. Fifty-three children of the 60 enrolled completed the study. After the 4-week crossover trial, the severity of nasal obstruction of 24 children (45%) significantly decreased during the use of nasal steroids, but no child improved when saline solution was used. At 24, 52, and 100 weeks, the 24 children who had initially improved showed a significant decrease of the severity of nasal obstruction and of the frequency of adenotonsillectomy (54% vs 83%) compared with the 29 children who had not responded after the initial steroidal therapy.

Conclusions. Evidence from this study suggests that 45% of children with adenoidal hypertrophy improved after 2 weeks of steroidal therapy. Among these children, an additional 24-week treatment at a lower steroid dosage was associated with a significant 52- and 100-week clinical improvement and with reduction of adenotonsillectomy compared with children (55%) who had not responded after the initial 2-week steroidal therapy.

Key Words: adenotonsillar hypertrophy • topical steroids • adenotonsillectomy

Received for publication Aug 19, 2002; Accepted Nov 12, 2002.




This article has been cited by other articles:


Home page
 Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (25 Apr 2003 to 18 Jul 2003)
Evid. Based Nurs., October 1, 2003; 6(4): e1 - 12.
[Full Text]